Literature DB >> 20180084

Complete resection after imatinib treatment of a gastrointestinal stromal tumor of the ileum with peritoneal metastases: report of a case.

Takashi Akiyoshi1, Masatoshi Oya, Yoshiya Fujimoto, Hiroya Kuroyanagi, Masashi Ueno, Toshiharu Yamaguchi, Shunji Takahashi, Kiyohiko Hatake, Masamichi Katori, Noriko Yamamoto, Tetsuichiro Muto.   

Abstract

A 70-year-old woman with a pelvic tumor had undergone exploratory laparoscopy at another institution, which revealed many peritoneal nodules. Immunohistochemical staining of a biopsy specimen of the peritoneal nodules was positive for KIT. Thus, a gastrointestinal stromal tumor (GIST) was diagnosed and imatinib treatment was begun. After 16 months of this treatment, the tumor size had decreased from 51 x 55 mm to 22 x 17 mm, and surgery was performed. Laparotomy revealed complete regression of the peritoneal lesions. The primary tumor was seen to arise from the small intestine and to loosely adhere to the rectum. We performed partial resection of the small intestine. Imatinib therapy was restarted 1 month postoperatively, and the patient is doing well after 12 months of follow-up. We report this case to show that there is the possibility of curative salvage surgery after long-term imatinib treatment in some patients with peritoneal metastases of a GIST.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180084     DOI: 10.1007/s00595-008-4037-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy.

Authors:  M Salazar; A Barata; S André; J Venâncio; I Francisco; M Cravo; C Nobre-Leitão
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 3.  Gastrointestinal stromal tumor (GIST).

Authors:  H Joensuu
Journal:  Ann Oncol       Date:  2006-09       Impact factor: 32.976

4.  Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

Authors:  J A Crosby; C N Catton; A Davis; J Couture; B O'Sullivan; R Kandel; C J Swallow
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

5.  The effect of surgery and grade on outcome of gastrointestinal stromal tumors.

Authors:  J P Pierie; U Choudry; A Muzikansky; B Y Yeap; W W Souba; M J Ott
Journal:  Arch Surg       Date:  2001-04

6.  Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.

Authors:  Maria Debiec-Rychter; Jan Cools; Herlinde Dumez; Raf Sciot; Michel Stul; Nicole Mentens; Hilde Vranckx; Bartosz Wasag; Hans Prenen; Johannes Roesel; Anne Hagemeijer; Allan Van Oosterom; Peter Marynen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

7.  Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.

Authors:  Alessandro Gronchi; Marco Fiore; Francesca Miselli; Maria Stefania Lagonigro; Paola Coco; Antonella Messina; Silvana Pilotti; Paolo Giovanni Casali
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

8.  Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.

Authors:  Jaap Verweij; Paolo G Casali; John Zalcberg; Axel LeCesne; Peter Reichardt; Jean-Yves Blay; Rolf Issels; Allan van Oosterom; Pancras C W Hogendoorn; Martine Van Glabbeke; Rossella Bertulli; Ian Judson
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

9.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

View more
  6 in total

1.  Gastrointestinal stromal tumor arising in an ileal duplication: report of a case.

Authors:  Kazushige Furuya; Masao Hada; Hidemitsu Sugai; Yoshiaki Miyasaka; Hiroshi Nakagomi; Toshio Oyama; Teruo Mitsui
Journal:  Surg Today       Date:  2012-02-04       Impact factor: 2.549

2.  Safe laparoscopic resection of a gastric gastrointestinal stromal tumor close to the esophagogastric junction.

Authors:  Yasuo Sakamoto; Yoshihisa Sakaguchi; Hisafumi Akimoto; Yoshiki Chinen; Miyako Kojo; Masahiko Sugiyama; Kazutoyo Morita; Hiroshi Saeki; Kazuhito Minami; Yuji Soejima; Yasushi Toh; Takeshi Okamura
Journal:  Surg Today       Date:  2012-01-24       Impact factor: 2.549

3.  Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case.

Authors:  Takatoshi Nakamura; Hiroyuki Mitomi; Wataru Onozato; Takeo Sato; Atsushi Ikeda; Masanori Naito; Naoto Ogura; Hiroki Kamata; Akira Ooki; Masahiko Watanabe
Journal:  Surg Today       Date:  2012-11       Impact factor: 2.549

4.  Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: report of a case.

Authors:  Koji Ando; Eiji Oki; Masahiko Sugiyama; Yan Zhao; Aya Kojima; Hidetaka Yamamoto; Yoichi Yamashita; Hiroshi Saeki; Akinobu Taketomi; Masaru Morita; Yoshihiro Kakeji; Shunichi Tsujitani; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

5.  Malignant jejunal gastrointestinal stromal tumor with history of prostate cancer: A case report.

Authors:  Sheng-Cai Wei; Wan-Hu Li; Liang Xu; Wen-Wu Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

6.  A large esophageal gastrointestinal stromal tumor that was successfully resected after neoadjuvant imatinib treatment: case report.

Authors:  Senichiro Yanagawa; Kazuaki Tanabe; Takahisa Suzuki; Noriaki Tokumoto; Koji Arihiro; Hideki Ohdan
Journal:  World J Surg Oncol       Date:  2014-02-27       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.